Inositol: a growing category with well-understood production requirements
Inositol is a naturally occurring sugar alcohol found in fruits, beans, and grains, and synthesized by the body from glucose. In dietary supplement manufacturing, the relevant forms are myo-inositol — the dominant naturally occurring isomer — and D-chiro-inositol, a downstream metabolite that participates in insulin signal transduction. The two forms are often co-formulated in the physiological 40:1 ratio (myo:D-chiro) for products targeting hormonal balance and metabolic support.
What drives inositol's current market position is a combination of growing consumer awareness of PCOS as an addressable condition, renewed interest in metabolic wellness as GLP-1 drug awareness has expanded the audience for insulin-sensitizing supplements, and a research base that supports structure/function claims across hormonal balance, insulin metabolism, and mood support. Brands entering this category need a manufacturing partner capable of producing accurately dosed inositol in powder and capsule formats from 5,000 units — not minimum runs in the hundreds of thousands that push independent and emerging brands to offshore suppliers with poor documentation practices.
Powder and capsule formats
Inositol is well-suited to both primary delivery formats Sun produces. The choice between them is largely driven by the target consumer and brand positioning rather than manufacturing constraints.
Inositol powder — stand-up pouches
Myo-inositol is highly water-soluble — it dissolves cleanly in water with minimal mixing, making it one of the more consumer-friendly powder supplements to formulate. Sun produces inositol powder in stand-up pouches, typically in 100g to 300g fill weights depending on serving size and SKU configuration. A standard 2g myo-inositol serving fits in a single measured scoop or single-serve sachet format. The powder format is dominant in the PCOS-focused consumer segment, where 2–4g daily doses are common and the dissolving behavior is part of the daily ritual the consumer engages with.
Inositol capsules — two-piece fill
Inositol powder fills cleanly into two-piece capsules in gelatin, HPMC, or pullulan shells. Typical capsule configurations range from 500mg to 1,000mg per capsule, with serving sizes of 2–4 capsules daily for 1–2g myo-inositol per serving. The capsule format suits consumers who prefer pill-form supplementation and brands targeting a broader wellness audience beyond the PCOS-specific segment. HPMC and pullulan shells support clean-label and vegan positioning for the plant-based segment of the hormonal and metabolic wellness market.
Inositol forms Sun manufactures
Myo-inositol
The most abundant naturally occurring inositol isomer and the primary raw material in most inositol supplement formulations. Myo-inositol functions as a cellular signaling molecule — acting as a precursor to second messengers involved in normal insulin signaling and supporting healthy hormonal axis function. It is well-characterized in the published literature for its role in supporting normal ovarian function, healthy menstrual cycle regularity, and metabolic balance. Produced in powder and capsule formats from 5,000 units.
D-chiro-inositol
D-chiro-inositol is a downstream metabolite of myo-inositol that participates in a complementary arm of the insulin signaling pathway. It is present in smaller quantities in the body than myo-inositol and less abundant in foods. D-chiro-inositol is less common as a standalone supplement but is routinely co-formulated with myo-inositol for combination products. We source D-chiro-inositol separately from qualified suppliers and produce it as both a standalone ingredient and a component of combination formulas.
40:1 myo-inositol / D-chiro-inositol combination
The 40:1 combination reflects the approximate physiological ratio of these two forms in human plasma and is the standard formulation used in published clinical studies examining inositol's role in hormonal balance and metabolic support. This combination is the most commercially prevalent inositol product formulation in the PCOS-support and hormonal wellness category. We produce the 40:1 blend in both powder and capsule formats, verifying the blend ratio through raw material weigh-in documentation and blend uniformity testing before fill begins.
Custom inositol blends
Inositol is frequently co-formulated with complementary actives — for example, inositol plus chromium picolinate for a metabolic support formula, inositol plus folate for preconception positioning, or inositol plus magnesium for a stress-and-hormonal balance stack. We develop multi-ingredient blends anchored by inositol from your brief or incorporate your existing validated formula. Blend development includes excipient review, flow testing, and batch uniformity verification before any production commitment.
Production specifications
| MOQ | 5,000 units |
|---|---|
| Inositol forms | Myo-inositol, D-chiro-inositol, 40:1 combination blend |
| Powder packaging | Stand-up pouches — 100g, 200g, 300g fill weight configurations |
| Capsule shell materials | Gelatin (bovine/porcine), HPMC (vegetarian), pullulan (vegan-certifiable) |
| Capsule sizes | Size 0 or 00 standard for inositol (500mg–1,000mg fill per capsule) |
| Bottle packaging | HDPE or PET bottles — 60-count, 90-count, 120-count configurations |
| Labeling | Pressure-sensitive labels; full-wrap shrink sleeve on request |
| Third-party testing | Every batch — active ingredient identity and potency, microbial safety, label claim validation |
| Lead time | 6–8 weeks from formula approval and component arrival |
| Documentation | Batch records and Certificate of Analysis with every production run |
The inositol manufacturing process from brief to finished goods
- Discovery call. We discuss your formula concept or existing specification, format preferences (powder, capsules, or both), inositol form and dose per serving, packaging configuration, and MOQ. We quote within one business day with specific costs — not ranges that require follow-up to interpret.
- Formula review or development. If you bring a validated formula, we review it for raw material compatibility, fill weight, and blend flow characteristics. If you're starting from a brief, we develop the formula — selecting inositol form, dose, excipients, and co-actives — and produce bench samples for your approval.
- Sample approval. You receive production-representative samples. Once you approve the formula specification and packaging, no changes are made without a new sample approval cycle. This is how label claims stay defensible against what's actually in the bottle.
- Component procurement. Myo-inositol is widely available from established suppliers. D-chiro-inositol has a narrower sourcing pool and longer lead times; we manage procurement of both components concurrently when timelines allow. We hold qualified supplier relationships for each form.
- Production. Blending and filling run on in-house production lines under full cGMP batch documentation. For combination blends, raw material weigh-in is documented at each component and blend uniformity is verified before fill commences. In-process weight checks run throughout the production run.
- Third-party testing. Every batch goes to an independent accredited laboratory for inositol identity and potency verification, microbial safety panels, and label claim validation. For 40:1 combination products, both myo-inositol and D-chiro-inositol concentrations are confirmed against label claim.
- Packaging, labeling, and case-packing. Finished units are labeled and case-packed to your retail or DTC configuration — retail-shelf-ready cases, Amazon FBA-ready pallets, or individual direct-ship cartons. FNSKU labeling for Amazon programs is accommodated.
- Fulfillment. Finished goods can move from our facility to your warehouse, to Amazon fulfillment centers, or through Sun's integrated fulfillment operation.
Who manufactures inositol with Sun
Inositol supplement demand is concentrated in two overlapping consumer segments: women managing hormonal and metabolic health (particularly PCOS-focused buyers) and the broader metabolic wellness market that has expanded alongside GLP-1 drug awareness. Brands targeting either segment are building direct-to-consumer and Amazon channels, and the smaller MOQ requirements of independent brands in this space make Sun's 5,000-unit starting point a practical fit.
- Women's hormonal wellness brands building PCOS-support product lines around myo-inositol and the 40:1 combination — frequently capsule-format products positioned alongside supplements like magnesium, NAC, and berberine
- Metabolic wellness brands formulating inositol into blood sugar support and insulin sensitivity stacks, often co-formulated with chromium picolinate, cinnamon extract, or berberine
- Preconception and fertility supplement brands where inositol appears alongside folate, CoQ10, and other prenatal-adjacent actives in formulations for women trying to conceive
- DTC brands launching inositol as a standalone or combination SKU targeting the growing segment of consumers who have encountered myo-inositol through social media, health content, or practitioner recommendation
- Practitioner-line supplement programs carrying inositol as part of a functional medicine formulation protocol, often in smaller run sizes where Sun's 5,000-unit MOQ is a direct fit
Compliance and label claims for inositol
Inositol supplements are produced and labeled under FDA's structure/function claim framework. Appropriate claims describe how inositol supports normal physiological function — for example, "supports healthy hormonal balance," "promotes normal insulin metabolism," "maintains healthy ovarian function," or "supports a healthy menstrual cycle." Framing that references disease treatment — "treats PCOS," "prevents insulin resistance" — falls outside the structure/function lane and is not appropriate for dietary supplement labels.
The structure/function claim framework is workable for inositol because the ingredient has a growing research base supporting its role in normal hormonal and metabolic function. The key to defensible claims is specificity — "supports normal ovarian function" is more defensible than "balances hormones." We review every formula and label for compliance with structure/function standards before any production commitment is made.
Frequently asked questions
What is the minimum order quantity for inositol manufacturing?
Our standard MOQ for inositol powder and capsule programs is 5,000 units. Contact us with your format preference, serving size, and packaging configuration — we'll quote a specific MOQ within one business day.
What forms of inositol do you manufacture?
We manufacture myo-inositol (the primary and most abundant form), D-chiro-inositol, and the 40:1 myo-inositol to D-chiro-inositol combination blend — the ratio that reflects the physiological proportion in human plasma and is most commonly formulated for hormonal balance products. Both standalone forms and the combination are available in powder and capsule formats.
Can you produce inositol in both powder and capsule formats?
Yes. Inositol is well-suited to both powder and capsule production. Myo-inositol powder dissolves readily in water, making stand-up pouch packaging effective for single-serve or scoop-access configurations. The capsule format suits consumers who prefer pill-form supplementation or more precise dosing. We produce both from the same validated raw material.
What capsule shell materials are available for inositol capsules?
We fill inositol capsules in gelatin (bovine or porcine), HPMC (vegetarian/hypromellose), and pullulan (vegan-certifiable). Inositol is plant-derived and compatible with all three shell materials. Brands positioning inositol products to a health-conscious, plant-based, or PCOS-focused consumer base frequently select HPMC or pullulan to support a clean-label story.
What is the difference between myo-inositol and D-chiro-inositol?
Myo-inositol is the predominant naturally occurring form of inositol and functions as a cellular second messenger involved in normal insulin signaling and healthy hormonal balance. D-chiro-inositol is a metabolite of myo-inositol that participates in a complementary arm of insulin signal transduction. The two forms work in separate but related pathways — which is why the 40:1 combination ratio, reflecting the natural physiological proportion in human plasma, is commonly co-formulated for products targeting metabolic and hormonal wellness.
How long does inositol manufacturing take from formula approval?
Typical lead time is 6 to 8 weeks from final formula approval and component arrival to finished goods. Myo-inositol is a widely available raw material, which keeps sourcing timelines short relative to exotic or novel actives. Combination blends require both components in spec; we manage procurement of myo-inositol and D-chiro-inositol concurrently.
Do you provide third-party testing on inositol batches?
Yes. Third-party laboratory testing is standard on every inositol batch — active ingredient identity and potency confirmation, microbial safety panel, and label claim validation. For 40:1 combination products, both myo-inositol and D-chiro-inositol concentrations are confirmed against label claim. A Certificate of Analysis is provided with every production run.
What label claims are appropriate for inositol supplements?
Inositol supplements are marketed under FDA's structure/function claim framework. Appropriate claims describe how inositol supports normal physiological function — for example, 'supports healthy hormonal balance,' 'promotes normal insulin metabolism,' 'maintains healthy ovarian function,' or 'supports a healthy menstrual cycle.' Claims that state or imply treatment of a disease — 'treats PCOS,' 'prevents insulin resistance' — are not appropriate for dietary supplement labels. We review label copy for compliance before any production commitment.
Can you produce a 40:1 myo-inositol to D-chiro-inositol blend?
Yes. The 40:1 myo-inositol to D-chiro-inositol combination is the standard formulation for combination inositol products and the ratio most commonly cited in published hormonal and metabolic wellness research. We produce this blend in both powder and capsule formats, verifying the blend ratio through raw material weigh-in documentation and blend uniformity testing before fill.